Clinical Trial Update: Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025) [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of the antiemetic EUR-1025 evaluating the effect of food on absorption; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea

Drugs mentioned

• EUR-1025

Snippet

Sponsor: Forest Laboratories | Conditions: Nausea | Phase 1 | Status: COMPLETED